Status: current, Defined. Date: 31-Aug 2018. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2681051000168113 | Olmesartan HCT 20/12.5 (GPPL) (hydrochlorothiazide 12.5 mg + olmesartan medoxomil 20 mg) tablet, 10 tablets, blister pack (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2681061000168110 | Olmesartan HCT 20/12.5 (GPPL) tablet, 10, blister pack | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Olmesartan HCT 20/12.5 (GPPL) (hydrochlorothiazide 12.5 mg + olmesartan medoxomil 20 mg) tablet, 10 tablets, blister pack (containered trade product pack) | Is a | Olmesartan HCT 20/12.5 (GPPL) tablet, 10 | true | Inferred relationship | Some | ||
| Olmesartan HCT 20/12.5 (GPPL) (hydrochlorothiazide 12.5 mg + olmesartan medoxomil 20 mg) tablet, 10 tablets, blister pack (containered trade product pack) | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Olmesartan HCT 20/12.5 (GPPL) (hydrochlorothiazide 12.5 mg + olmesartan medoxomil 20 mg) tablet, 10 tablets, blister pack (containered trade product pack) | has TPUU | Olmesartan HCT 20/12.5 (GPPL) tablet | true | Inferred relationship | Some | 1 | |
| Olmesartan HCT 20/12.5 (GPPL) (hydrochlorothiazide 12.5 mg + olmesartan medoxomil 20 mg) tablet, 10 tablets, blister pack (containered trade product pack) | has container type | blister pack | true | Inferred relationship | Some | ||
| Olmesartan HCT 20/12.5 (GPPL) (hydrochlorothiazide 12.5 mg + olmesartan medoxomil 20 mg) tablet, 10 tablets, blister pack (containered trade product pack) | has TP | Olmesartan HCT 20/12.5 (GPPL) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Description inactivation indicator reference set
Containered trade product pack reference set
FHIR